Chromone as a privileged scaffold in drug discovery: recent advances: miniperspective

J Reis, A Gaspar, N Milhazes… - Journal of medicinal …, 2017 - ACS Publications
The use of privileged structures in drug discovery has proven to be an effective strategy,
allowing the generation of innovative hits/leads and successful optimization processes …

Synthesis of biologically active molecules through multicomponent reactions

D Insuasty, J Castillo, D Becerra, H Rojas, R Abonia - Molecules, 2020 - mdpi.com
Focusing on the literature progress since 2002, the present review explores the highly
significant role that multicomponent reactions (MCRs) have played as a very important tool …

Site-selective acceptorless dehydrogenation of aliphatics enabled by organophotoredox/cobalt dual catalysis

MJ Zhou, L Zhang, G Liu, C Xu… - Journal of the American …, 2021 - ACS Publications
The value of catalytic dehydrogenation of aliphatics (CDA) in organic synthesis has
remained largely underexplored. Known homogeneous CDA systems often require the use …

Organofluorine chemistry: Promising growth areas and challenges

LV Politanskaya, GA Selivanova… - Russian Chemical …, 2019 - iopscience.iop.org
Currently, the chemistry of organofluorine compounds is a leading and rapidly developing
area of organic chemistry. Fluorine present in a molecule largely determines its specific …

Apigenin as neuroprotective agent: Of mice and men

SF Nabavi, H Khan, G D'onofrio, D Šamec… - Pharmacological …, 2018 - Elsevier
Neurodegenerative disorders (NDDs) such as Alzheimer's and Parkinson's diseases are the
most common age-related pathologies that affect millions of people all over the world. To …

Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors

R Basri, S Ullah, A Khan, SN Mali, O Abchir, S Chtita… - Bioorganic …, 2023 - Elsevier
Abstract Type-2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders in
the world and over the past three decades its incidence has increased drastically. α …

Chromones: Privileged scaffold in anticancer drug discovery

VM Patil, N Masand, S Verma… - Chemical Biology & …, 2021 - Wiley Online Library
In the design and discovery of anticancer drugs, various natural heterocyclic scaffolds have
attracted considerable interest as privileged structures. For rational drug design, some of the …

Synthesis of newer 1, 2, 3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities

R Kant, D Kumar, D Agarwal, RD Gupta, R Tilak… - European journal of …, 2016 - Elsevier
The present study was carried out in an attempt to synthesize a new class of antimicrobial
and antiplasmodial agents by copper catalyzed click chemistry to afford 25 compounds 10 …

Visible-light-induced metal-free coupling of C (sp 3)–H sources with heteroarenes

A Ghosh, P Pyne, S Ghosh, D Ghosh, S Majumder… - Green …, 2022 - pubs.rsc.org
Development of an efficient, mild, economically viable, and green method for the
construction of a Csp2–Csp3 bond via coupling between a saturated hydrocarbon [(Csp3) …

Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities

S Emami, Z Ghanbarimasir - European Journal of Medicinal Chemistry, 2015 - Elsevier
Chroman-4-one scaffold is a privileged structure in heterocyclic chemistry and drug
discovery. Also, chroman-4-ones are important intermediates and interesting building blocks …